Thu 5 Feb 2015, 09:00:
Recent Applications of Enzyme and Metabolic Engineering for Chemical Synthesis
Xinkai Xie got his Ph.D. degree from Dr. Yi Tang’s group at UCLA and did postdoc work at Jay Keasling’s lab at UC Berkeley. During his Ph.D. study, he developed a biotransformation process for simvastatin synthesis which was licensed to Codexis and Teva, and won the presidential green chemistry challenge award. Xinkai Xie joined Codexis after postdoc in 2011 and then joined EnzymeWorks at the end of 2013, where he is currently Director of R&D.